-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the statistics of thePharmaceutical Network Market Analysis
, as of May 20, the State Drug Administration has announced that 345 injections of the participating formulations (in terms of drug names), of which 144 injections have not yet been submitted by enterprises to submit a supplementary application for consistency evaluation or according to the newly registered classification of productionOf the 144 injections, 10 are large varieties with terminal sales of more than 1 billion yuan in China's public medical institutions in 2019specifically, these 10 large varieties include sodium cephalosporine for injection, sodium perancetine with injection, acrytamine injection with acrytamine, zocanitin injection, sodium cephalosporine with injection cephalosporine, hydroxyethy starch 130/04 sodium chloride injection, lilac acid butorinin injection, injection of butyl sulfonate methionine, injection with multivitamin (12), pediatric compound amino acid injection (19AA-I)/pediatric compound amino acid injection (18AA-II)Sales of sodium cephalosporinefor injection: $2,189 million
data show that sodium cephalosporine is used for injection, and indications are pneumonia and other lower respiratory tract infections caused by sensitive bacteriaInjection with amine penanasitosinsales: 2808 million yuan
data show that the injection of amine penanasitributia sodium as a prescription drug, suitable for a variety of pathogens and oxygen/anaerobic bacteria-induced mixed infections, comprehensive treatment of a variety of moderate and severe infections; Developed and produced by MersadongSales of acrytamine injection sin
sales: 2,196 million yuan
data show that the acetaminophen injection, the indications are suitable for patients who need to supplement glutamine out-of-intestinal nutrition, including those in the breakdown and metabolism and high metabolic status Zucanitin injection sales: 2,158 million yuan
data show that the zocanitin injection, indications for chronic renal failure of long-term hemorrhagic patients due to secondary carnitine deficiency of a series of complications Sales
of sodium cephalosporine mendoeste for injection: 1,889 million yuan
data show that sodium cephalosporine is used for lung infections caused by sensitive bacteria, etc Hydrohyely starch 130/0.4 sodium chloride injection sales: 1,732 million yuan
data show that hydroxyeroxystarch 130/0.4 sodium chloride injection treatment and prevention of insufficient blood capacity, acute isostatic blood dilution (ANH) Sales of tatric acid butorine injections sales: 1,659 million yuan
data show that tatric acid butorine injection sindications are used to treat various types of canceral pain, post-operative pain Injection with disulplyine sales: 1.395 billion yuan
data show that injection with butyl sulfonate adenosine methionine, applied to pre-cirrhosis and liver cirrhosis caused by the liver bile accumulation sales of multivitamins (12) for injections: 1,194 million yuan
data show that multivitamins for injection (12) are suitable for patients who need to take vitamin supplements by injection according to the daily vitamin intake needs of adults and children over 11 years of age Children's compound amino acid injection (19AA-I) / pediatric compound amino acid injection (18AA-II) sales: 10.55 billion yuan data show that pediatric compound amino acid injection (19AA-I) is suitable for refractory diarrhea, absorption syndrome and premature infant, low-weight children's intestinal nutrition Conclusion the industry believes that with the promotion of consistency evaluation, band procurement and other policies, as well as the current injection consistency evaluation guidance, and the speed of review greatly increased (completed within 120 days after acceptance) Once the consistency evaluation is a key factor, the inclusion of more injections in the collection is a matter of water-to-water, when the injection will officially enter the "national harvest and provincial harvest" division surrounded by a new stage.